UPDATE : Monday, September 7, 2020
상단여백
Analyst warns of possible ‘bubble’ amid bio-share surge
An analyst from Hana Financial Investment Corp. warned against a short-term...
by Lee Han-soo  |  2018-01-23 15:15
라인
Shares of ‘Celltrion trio’ plummet on profit-taking
Shares of Celltrion and its two affiliated firms plunged on Wednesday, and ...
by Nam Doo-hyun  |  2018-01-18 11:10
라인
Shares of eye drops/masks makers rise on fine dust measure
Shares of manufacturers of eye drops and masks have risen on Monday, with t...
by Nam Doo-hyun  |  2018-01-15 15:48
라인
Luxturna to open gene therapies market: analyst
The latest approval by the U.S. Food and Drug Administration for Luxturna, ...
by Nam Doo-hyun  |  2018-01-10 15:48
라인
Bio-shares on the rise
Bio-industry shares are on the rise amid expectations for favorable governm...
by Lee Han-soo  |  2018-01-09 15:26
라인
Celltrion’s market cap exceeds 36 trillion won
Celltrion has emerged as the fourth largest company by market capitalizatio...
by Lee Han-soo  |  2018-01-08 12:27
라인
Drugmakers rush to attend JP Morgan’s healthcare event
Many local pharmaceutical and biotech companies plan to attend J.P. Morgan’...
by So Jae-hyeon  |  2018-01-08 11:44
라인
Celltrion stocks jump on expectations of rising market share
Investors are paying attention to Celltrion, the local leader in the develo...
by Lee Han-soo  |  2018-01-04 16:40
라인
Venture capital investment in biomedical sector drops 20% in 2017
Venture capital investment in the local biomedical sector declined by 20 pe...
by Nam Doo-hyun  |  2018-01-04 09:30
라인
Samyang Biopharm wins patent suit against Helsinn Healthcare
Samyang Biopharm said Wednesday that it has won a patent suit on Palseron (...
by Lee Han-soo  |  2018-01-03 16:58
라인
70% of biotech firms enjoy stock price gains in 2017
In the South Korean stock market, biopharmaceutical and pharmaceutical firm...
by Nam Doo-hyun  |  2018-01-02 17:42
라인
HanAll vice chairman sells off stake despite export deal
HanAll Biopharma Vice Chairman Kim Sung-wuk unexpectedly sold off part of h...
by So Jae-hyeon  |  2018-01-02 13:57
라인
Kolon Life Science’s shares plummet on drifting export deal
Kolon Life Science’s shares plummeted by 15 percent on Wednesday from the p...
by Nam Doo-hyun  |  2017-12-21 13:16
라인
HanAll inks $30 million tech export deal
HanAll Biopharma said it signed a $30 million deal with a U.S. company to t...
by So Jae-hyeon  |  2017-12-20 15:49
라인
￦500-billion Invossa technology export to Japan in peril
Mitsubishi Tanabe Pharma notified Kolon Life Science that the Japanese drug...
by Nam Doo-hyun  |  2017-12-20 14:59
라인
FDA to review Samsung Bioepis’ trastuzumab biosimilar
Samsung Bioepis said Tuesday that the U.S. Food and Drug Administration (FD...
by Lee Han-soo  |  2017-12-20 14:37
라인
Nature Cell expects to receive conditional approval for Jointstem
Nature Cell showed confidence in obtaining conditional approval for Jointst...
by Lee Han-soo  |  2017-12-19 18:22
라인
‘Celltrion’s annual revenue to top ￦3 trillion in 5 years’
Celltrion, which recently obtained Europe’s approval for breast cancer trea...
by Nam Doo-hyun  |  2017-12-18 15:55
라인
Samsung Bioepis, Daewoong sign exclusive supply contract for Samfenet
Samsung Bioepis and Daewoong Pharmaceuticals have signed an exclusive suppl...
by Lee Han-soo  |  2017-12-18 10:59
라인
Corestem’s NeuroNata-R marks increase in foreign patients
The number of foreign patients visiting Korea to use Corestem’s NeuroNata-R...
by Lee Han-soo  |  2017-12-15 16:22
-이전21222324252627282930-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top